DGAT1 Expression Promotes Ovarian Cancer Progression and Is Associated with Poor Prognosis
Background. Ovarian cancer is the most fatal gynecological malignancy. Owing to its insidious onset, rapid development, and poor prognosis, ovarian cancer is the fifth most common cause of death in women. Although immunotherapy-related drugs, such as Olaparib, can alleviate ovarian cancer progressio...
Saved in:
Main Authors: | Leilei Xia, Ye Wang, Shengyun Cai, Mingjuan Xu |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-01-01
|
Series: | Journal of Immunology Research |
Online Access: | http://dx.doi.org/10.1155/2021/6636791 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
LURAP1L-AS1 long noncoding RNA promotes breast cancer progression and associates with poor prognosis
by: Radhakrishnan Vishnubalaji, et al.
Published: (2025-06-01) -
Overexpression of Notch3 and pS6 Is Associated with Poor Prognosis in Human Ovarian Epithelial Cancer
by: Zhaoxia Liu, et al.
Published: (2016-01-01) -
FGFRL1 Promotes Ovarian Cancer Progression by Crosstalk with Hedgehog Signaling
by: Haiyan Tai, et al.
Published: (2018-01-01) -
SECTM1 acts as an immune-related biomarker of poor prognosis and promotes cancer progression by modulating M2 macrophage polarization in esophageal squamous cell carcinoma
by: Pengzhou Kong, et al.
Published: (2025-01-01) -
High Expression of Ten Eleven Translocation 1 Is Associated with Poor Prognosis in Hepatocellular Carcinoma
by: Haopeng Wen, et al.
Published: (2023-01-01)